3'-O-Methylcytidine is a modified nucleoside intermediate, structurally derived from cytidine by methylation at the 3' hydroxyl group of the ribose moiety. It is used primarily as a building block in the synthesis of modified oligonucleotides for research and pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 20594-00-7
2'-O-methylcytidine
pharmaceutical intermediate
Ac-2'-OMe-C
pharmaceutical intermediate
2'-O-Methyladenosine
pharmaceutical intermediate
2'-O,4'-C-Methylenecytidine
pharmaceutical intermediate
LNA-Adenosine
pharmaceutical intermediate
N-(9-((1R,3R,4R,7S)-1-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-7-hydroxy-2,5-dioxabicyclo[2.2.1]heptan-3-yl)-9H-purin-6-yl)benzamide
pharmaceutical intermediate
(1R,3R,4R,7S)-1-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2,5-dioxabicyclo[2.2.1]heptan-7-yl (2-cyanoethyl) diisopropylphosphoramidite
pharmaceutical intermediate
4-amino-1-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxyoxolan-2-yl]pyrimidin-2-one
RZJCFLSPBDUNDH-ZOQUXTDFSA-N
CO[C@@H]1[C@H](O[C@H]([C@@H]1O)N2C=CC(=NC2=O)N)CO